Subscribe
Close
  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Renew

Vantive Plans Deerfield, Illinois, Headquarters Operations

05/10/2025
Vantive, formerly the Kidney Care segment of Baxter International, a vital organ therapy company, plans to establish operations in Deerfield, Illinois. The $23 million project is expected to create 50 jobs.

The company’s new U.S. headquarters will enable it to expand its office facilities and pharmacy operations.

"We are proud to continue our legacy of innovation in Deerfield, Illinois, which has served as an important anchor for our mission-driven work over the last several decades," said Vantive CEO Chris Toth. "Illinois offers a strong healthcare ecosystem, a highly skilled workforce, and a supportive business environment - all of which provide an ideal foundation for Vantive's next phase of success. Our new headquarters is designed to inspire collaboration, creativity, and excellence as we work to advance our mission to extend lives and expand possibilities for patients globally. We thank our partners in the State of Illinois for their immense support and look forward to continuing our collaboration."

The project will be supported by an Economic Development for a Growing Economy (EDGE) tax credit.

"Vantive's decision to establish their U.S. headquarters in Illinois is a significant win for our state and a testament to all that we have to offer," noted Illinois Department of Commerce and Economic Opportunity (DCEO) Director Kristin Richards. "Illinois is a hub for innovation with a robust and growing life sciences industry. We are committed to investing and supporting companies that not only bring innovative technology to Illinois but also create good-paying jobs."

Vantive offers innovative products, digital solutions, and advanced services designed to support both home and clinic-based dialysis, as well as critical care therapies for the kidney and other vital organs in intensive care units.

Exclusive Research